WHO ICTRP trial
Comparing the effect of immunotherapy with hydroxychloroquine and vitamin D3
IRCT20250507065634N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20250507065634N3 |
|---|---|
| Public title | Comparing the effect of immunotherapy with hydroxychloroquine and vitamin D3 |
| Scientific title | Comparative study of the effect of immunotherapy with hydroxychloroquine and vitamin D3 compared to vitamin D3 alone in patients with recurrent miscarriage |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Condition 1: Recurrent Pregnancy Loss. Condition 2: Spontaneous abortion. Pregnancy care for patient with recurrent pregnancy loss Spontaneous abortion;O26.2 |
| Interventions | Intervention 1: Control group: They will receive oral vitamin D3 1000 units daily after a positive pregnancy test and confirmation of intrauterine pregnancy with serial pregnancy tests or vaginal ultrasound until the 20th week of pregnancy… |
| Registration date | Aug 24, 2025 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: